Elanco Animal Health Inc (NYSE:ELAN)
$ 14.07 -0.43 (-2.97%) Market Cap: 6.96 Bil Enterprise Value: 10.82 Bil PE Ratio: 35.18 PB Ratio: 1.07 GF Score: 72/100

Elanco Animal Health Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 11, 2023 / 08:15PM GMT
Release Date Price: $11.78 (+1.64%)
Erin Elizabeth Wilson Wright
Morgan Stanley, Research Division - Equity Analyst

Hi. Good afternoon, everybody. My name is Erin Wright. I'm the lead health care services analyst at Morgan Stanley. We're happy to have with us today Elanco Animal Health. We have the management team here. We have Jeff Simmons, the CEO with us up on the podium here and then also Todd Young in the audience, the CFO; and IR, Katy Grissom as well, who leads up the IR effort there. So happy to have you. I'm glad you can come and welcome, I think I hand it to you for just some intro remarks, if you want to give those and then we can hop right into Q&A.

Jeffrey N. Simmons
Elanco Animal Health Incorporated - President, CEO & Director

Great. Thank you, everybody. Thanks for the interest in Elanco. So I think the headline is we are at an inflection point as a company, second largest independent animal health company. Next year will be our 70th year as a company, longest-standing brand in front of farmers, vets and pet owners. And we really are coming into kind of a historical time.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot